RYAN WALKER: Open Payments
NPI 1184258279 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$339 in 15 payments from 10 companies in 2025. Trend: 2023 $1,106 · 2024 $1,381 · 2025 $339
Food & beverage: $339
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $67 |
| Janssen Pharmaceuticals, Inc | 2 | $49 |
| Tris Pharma Inc | 2 | $41 |
| ABBVIE INC. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| Lundbeck LLC | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Corium, LLC | 2 | $18 |
Products named: Auvelity, REXULTI, SPRAVATO, Dyanavel XR, VRAYLAR, FANAPT, COBENFY, Qelbree.
Industry payments across FL — which companies pay providers there.
